ArticleInternational journal of molecular sciences2022

Potential Therapeutic Agents against Paclitaxel-And Sorafenib-Resistant Papillary Thyroid Carcinoma.

Seok-Mo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.